Loading company…
PepBio develops natural peptide libraries and platforms for peptide drug discovery.
Founded in 2021 and based in Chengdu, China, PepBio develops natural active peptide libraries and screening platforms using cloud computing and AI. Its work includes peptide drug research for pain, cardiovascular and cerebrovascular, and respiratory diseases. In December 2025, it closed a Series A round from Shangshan Capital to advance drug pipelines and AI-assisted development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in